ReviewBriefings in bioinformatics2025
The rise and potential opportunities of large language model agents in bioinformatics and biomedicine.
Review in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Coala: a standard-based framework for converting CWL-described command-line tools into agentic toolsets.Bioinformatics (Oxford, England) · 2026Article
- The Performance of Large Language Models in Extracting Intestinal Symptoms From Electronic Health Records: Retrospective Observational Study.Journal of medical Internet research · 2026Observational
- When intelligence begins to act: a thoughtful appraisal of agentic AI in biomedicine.Briefings in bioinformatics · 2026Article
- Large language model agents for biological intelligence across genomics, proteomics, spatial biology, and biomedicine.Briefings in bioinformatics · 2026Review
- Artificial Intelligence for Osteoporosis Diagnosis, Risk Prediction and Therapy: Current Advances, Clinical Challenges, and Future Perspectives.Clinical interventions in aging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Large language model (LLM) agents have demonstrated remarkable potential in the fields of bioinformatics and biomedicine. This paper reviews the technical foundations of LLM agents, including their core architecture, key technologies, and collaborative modes. We explore the applications of LLM agents in multi-omics, drug development, chemical research, clinical diagnosis, and health management. The paper also analyzes the major challenges faced by LLM agents, such as the interaction and extension of their frameworks, data privacy and security, model hallucinations and interpretability, timeliness of knowledge updates, and ethical and legal risks. Furthermore, we discuss future directions, including paradigms for human-artificial intelligence collaboration and the development of open-source ecosystems and standardization. This paper aims to provide a comprehensive perspective and guidance on the advancement of LLM agents in bioinformatics and biomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.